CA-VELODYNE-LIDAR
3.1.2019 14:02:11 CET | Business Wire | Press release
Velodyne Lidar, Inc. will introduce and demonstrate its breakthrough new lidar sensor technology at CES 2019 in the Las Vegas Convention Center North Hall, booth #9010. Velodyne will present product demonstrations showing how lidar is advancing vehicle autonomy, safety, and advanced driver assistance systems (ADAS). The in-booth press conference will announce exciting collaborations and strategic partnerships, never-before-seen products, and customer achievements on Wednesday, January 9, at 11:00 a.m. PST.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190103005186/en/
Velodyne will showcase a wide array of products that fully meet all of the auto industry’s lidar needs, including new products to address directional and short-range sensing with trailblazing technology and performance. Velodyne will also introduce complete lidar-based safety solutions that incorporate Velodyne hardware and software. For more details, please see the Velodyne CES new product release on Tuesday, January 8, at 9:00 a.m. PST.
“The new products we are unveiling at CES advance Velodyne’s leadership position in providing the smartest, most powerful lidar solutions for autonomy and driver assistance,” said Anand Gopalan, Ph.D., Chief Technology Officer (CTO) at Velodyne Lidar. “Delivering integrated hardware and software safety solutions is extremely valuable to automakers with the technologies seamlessly working together to provide breakthrough advanced driver assistance systems.”
At CES, live demonstrations of Velodyne’s lidar sensors will show their industry-leading combination of long range, high resolution, and wide field of view. Visitors to the Velodyne booth can experience a lidar point cloud via augmented reality. Velodyne partners also will lead in-booth presentations, unveil new technologies, and demonstrate lidar’s use in autonomy, marine, agriculture, and emerging industries.
Velodyne demonstrations at CES will include:
Velodyne Alpha Puck™. The culmination of ten years of lidar development and learning from millions of road miles, the Alpha Puck is a sensor specifically made for autonomous driving and advanced vehicle safety at highway speeds. Perfect for Level 4-5 autonomy, the sensor produces an image best described as “stunning,” with the highest resolution data set in the world. It boasts the longest range for highway driving and maximum safety.
Velodyne Velarray™. The Velarray’s best-in-class range, resolution, and field of view facilitate robust object detection, allowing for longer braking distance and increased safety. Designed for seamless vehicle integration, this compact sensor generates a richly-detailed directional image, day or night. It can be concealed within roof lines, in bumpers, and - as demonstrated at CES - behind windshields.
The Velodyne booth will also feature Velodyne’s Augmented Reality demonstration that allows people to experience how autonomous vehicles see the world.
“At CES, people can come to the Velodyne booth to experience how our intelligent lidar sensors are enabling autonomous vehicles on the road today,” said Mike Jellen, president and chief commercial officer of Velodyne Lidar. “They can see how Velodyne’s rich computer perception data helps determine the safest way to navigate and direct a self-driving vehicle. Visitors to our booth can also learn how Velodyne’s versatile lidar sensors are utilized in a myriad of trailblazing applications in addition to self-driving cars and driver assistance, including unmanned aerial vehicles, mapping, industrial safety, robotics, security, and more.”
Cutting-Edge Customer and Partner Solutions
Velodyne will present products and presentations from its network of customers and partners that are using lidar technology in a range of innovative solutions. These partners include Accur8vision, AGC, Apex.AI, AutonomouStuff, DeepMap, Local Motors, MechaSpin, and Paracosm.
Accur8vision . Equipped with Velodyne lidar, Accur8vision provides an innovative approach to the security sector. Accur8vision is a volumetric detection system that protects an entire area needing to be secured, compared to perimetric detection which only guards the boundary. With Accur8vision and Velodyne lidar sensors, any intruder who enters the guarded area will never go undetected.
AGC. A world-leading supplier of flat, automotive, and display glass, as well as chemicals and other high-tech materials and components, AGC will showcase windshield technology from its WIDEYE task force. Wideye™ is focused on autonomous vehicles and solid-state lidar integration solutions. Combined with the Velarray™ sensor for an interactive demo in Velodyne’s booth, WIDEYE’s infrared transparent automotive-grade glass provides an ADAS and autonomous solution featuring both seamless design and safer perception.
Apex.AI . Apex.AI builds reliable, safe, and certified software for autonomous vehicles and other autonomous mobility systems. Apex.OS is an SDK compatible ROS 2 (Robot Operating System). It provides a production-grade, safety-certified real-time framework for developing safe and secure autonomous vehicle applications. Apex.Autonomy provides functional building blocks for autonomous vehicles on top of Apex.OS, such as libraries for 3D lidar perception including integration of Velodyne lidars.
AutonomouStuff . AutonomouStuff provides the best R&D platforms, products, software, and engineering services to aid in the advancement of robotics and autonomy. The company has provided solutions for automated driving to thousands of customers worldwide. In order to continue to rise up, companies must surround themselves with the best. This industry is no different. That is why AutonomouStuff chooses to surround itself with a market leader like Velodyne.
DeepMap . HD mapping is a crucial piece of the autonomous vehicle stack that needs to be robust, reliable, and highly scalable. DeepMap provides state-of-the-art mapping and localization to autonomous vehicles as a service. DeepMap helps its customers expedite their autonomous vehicle technology development in a safe and scalable way. Velodyne’s lidar is widely used by DeepMap and its customers for autonomous driving as well as mapping and localization.
Local Motors by LMI . Local Motors will show the world’s first co-created, electric, and self-driving shuttle, Olli. On display will be a current R&D prototype made of a nearly 90 percent 3D-Printed Olli and integrates a range of Velodyne sensors. Local Motors partnered with Velodyne to showcase how Velodyne sensors allow Olli to not only see in 360 degrees, but also ensures coverage of multiple overlapping areas at greater distance with more reliability.
MechaSpin . An industry-leading lidar sensor integrator, MechaSpin will showcase how it has utilized Velodyne’s lidar technology to develop an ecosystem of capabilities to provide solutions in the maritime, intermodal, agriculture, and material handling industries. MechaSpin’s proprietary MSx Processing Engine enables rapid adoption and integration of lidar sensor technology for custom applications.
Paracosm . Paracosm, a division of Occipital, develops PX-80, a handheld 3D mapping device that captures large-scale indoor and outdoor spaces in minutes using Velodyne’s Puck™ sensor. Its CES presentation will highlight exciting, real-world customer use cases from scanning aircraft hangars to the Amazon rainforest for a virtual reality film.
For more information on Velodyne and to download news releases, photos, and videos, please visit https://velodynelidar.com/newsroom/ . Media can schedule an executive interview or product demo by contacting Robin Carr at Landis Communications Inc. (415-971-3991; velodyne@landispr.com ).
About Velodyne Lidar
Velodyne provides the smartest, most powerful lidar solutions for autonomy and driver assistance. Founded in 1983 and headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. In 2005, Velodyne’s Founder and CEO, David Hall, invented real-time surround view lidar systems, revolutionizing perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the perfect for L4-L5 autonomy Alpha Puck™ and the directional view Velarray™.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190103005186/en/
Contact:
Robin Carr Landis Communications Inc. (415) 971-3991 velodyne@landispr.com www.landispr.com
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom